Lymphoma Research Foundation shared a post on LinkedIn:
“The Lymphoma Research Foundation’s Mantle Cell Lymphoma Consortium brings together the world’s leading mantle cell lymphoma experts to better understand this rare, aggressive subtype of lymphoma and to guide the path ahead for MCL research.
We are pleased to share that the findings from the Consortium’s 2025 Scientific Workshop have been published in Cancer.”
Charles Gaulin, Hematologic Oncologist and Assistant Professor of Medicine at Dartmouth Hitchcock Medical Center and Clinics, shared this post, adding:
“Exciting progress is on the horizon for mantle cell lymphoma patients. Deep molecular characterization and innovative clinical trial designs are paving the way for more personalized, highly effective MCL therapies.”
Title: 2025 Report on the Mantle Cell Lymphoma Scientific Consortium and Workshop Hosted by the Lymphoma Research Foundation
Author: Lymphoma Research Foundation
Read the Full Article.
Other articles about Lymphoma Research Foundation on OncoDaily.